2 transcripts
MDGL
Earnings call transcript
NASDAQ
2024 Q2
7 Aug 24
for women in the United States. They also recognize the clinical benefits of Rezdiffra for F2/F3 patients and that noninvasive tests or NITs, not biopsies
MDGL
Earnings call transcript
NASDAQ
2024 Q1
7 May 24
to be.
And then maybe if I could sneak this in, if semaglutide shows a fibrosis benefit that's in line with Rezdiffra and its upcoming Phase III trial, do you
- Prev
- 1
- Next